SVA Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$742K Buy
4,396
+74
+2% +$11K 0.06% 135
2020
Q3
$640K Sell
4,322
-280
-6% -$43.3K 0.06% 136
2020
Q2
$756K Buy
4,602
+780
+20% +$120K 0.08% 126
2020
Q1
$530K Hold
3,822
0.06% 143
2019
Q4
$502K Sell
3,822
-21
-0.5% -$2.43K 0.05% 149
2019
Q3
$430K Sell
3,843
-148
-4% -$16.5K 0.04% 157
2019
Q2
$442K Buy
3,991
+277
+7% +$32.6K 0.04% 159
2019
Q1
$482K Buy
3,714
+280
+8% +$34K 0.05% 155
2018
Q4
$397K Sell
3,434
-222
-6% -$24.8K 0.04% 160
2018
Q3
$392K Buy
3,656
+532
+17% +$53.2K 0.04% 166
2018
Q2
$267K Sell
3,124
-821
-21% -$67.4K 0.03% 189
2018
Q1
$337K Buy
3,945
+515
+15% +$41.5K 0.04% 168
2017
Q4
$290K Sell
3,430
-515
-13% -$43.8K 0.03% 182
2017
Q3
$337K Buy
3,945
+127
+3% +$10.4K 0.04% 168
2017
Q2
$314K Buy
3,818
+140
+4% +$11.4K 0.04% 163
2017
Q1
$309K Sell
3,678
-307
-8% -$24.6K 0.04% 161
2016
Q4
$293K Hold
3,985
0.04% 168
2016
Q3
$320K Sell
3,985
-89
-2% -$7.12K 0.05% 161
2016
Q2
$321K Sell
4,074
-715
-15% -$53.8K 0.05% 164
2016
Q1
$345K Sell
4,789
-756
-14% -$57.2K 0.06% 162
2015
Q4
$467K Buy
5,545
+40
+0.7% +$3.32K 0.08% 156
2015
Q3
$461K Sell
5,505
-785
-12% -$66.3K 0.09% 151
2015
Q2
$525K Hold
6,290
0.1% 149
2015
Q1
$457K Sell
6,290
-307
-5% -$21.9K 0.08% 161
2014
Q4
$455K Buy
6,597
+832
+14% +$56.2K 0.17% 122
2014
Q3
$374K Sell
5,765
-50
-0.9% -$3.17K 0.16% 118
2014
Q2
$362K Hold
5,815
0.15% 117
2014
Q1
$342K Buy
5,815
+424
+8% +$23.7K 0.16% 114
2013
Q4
$275K Buy
+5,391
New +$270K 0.16% 120

Other funds holding LLY

SVA Wealth Management's LLY Position: Q4 2020 in Review

SVA Wealth Management increased its Eli Lilly (LLY) stake by 1.7% in Q4 2020, buying an estimated $11K and bringing the position to 4,396 shares worth $742K. The position accounts for 0.06% of the portfolio, ranked #135.

SVA Wealth Management first reported a position in LLY in Q4 2013 and has held it in 29 quarters since. The position peaked at $756K in Q2 2020. 1,886 funds tracked by Wall St. Rank hold LLY as of Q4 2020.

  • SVA Wealth Management held 4,396 shares of Eli Lilly worth $742K as of Q4 2020.
  • SVA Wealth Management bought 74 Eli Lilly shares in Q4 2020, an estimated $11K.
  • Eli Lilly made up 0.06% of SVA Wealth Management's portfolio in Q4 2020, its #135 holding.
  • SVA Wealth Management first reported a position in Eli Lilly in Q4 2013 and has held it in 29 quarters since.
  • SVA Wealth Management's Eli Lilly position peaked at $756K in Q2 2020.
  • 1,886 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2020.

Based on SVA Wealth Management's 13F filing for Q4 2020, filed 4 Feb 2021.